Douglas Dahl, MD
Douglas M. Dahl, MD FACS is a Urologic Surgeon at the Massachusetts General Hospital in Boston, Massachusetts. He is the Chief of Urologic Oncology. He is an Associate Professor of Urology at Harvard Medical School. His expertise is in laparoscopic and robotic surgery for prostate cancer, kidney cancer, and reconstruction of the urinary tract. He is an expert in rare malignancies of the genito-urinary organs.
Financial relationships
-
Attribution:SelfType of financial relationship:Consultant or Advisor (General Urology)Ineligible company:CivcoDate added:Date updated:01/27/2022
-
Attribution:SelfType of financial relationship:Investment Interest (General Urology)Ineligible company:VertexDate added:Date updated:01/27/2022
-
Attribution:SelfType of financial relationship:Investment Interest (General Urology)Ineligible company:Tak PharmaceuticalsDate added:Date updated:01/27/2022
-
Attribution:SelfType of financial relationship:Investment Interest (Oncology)Ineligible company:NovartisDate added:Date updated:01/27/2022
-
Attribution:SelfType of financial relationship:Investment Interest (Specialty Not Specified)Ineligible company:Bristol Myers SquibbDate added:Date updated:01/27/2022
-
Attribution:SelfType of financial relationship:Investment Interest (Specialty Not Specified)Ineligible company:Eli LillyDate added:Date updated:01/27/2022
-
Attribution:SelfType of financial relationship:Investment Interest (Specialty Not Specified)Ineligible company:MerckDate added:Date updated:01/27/2022
-
Attribution:SelfType of financial relationship:Investment Interest (Specialty Not Specified)Ineligible company:GlaxoSmithKlineDate added:Date updated:01/27/2022
-
Attribution:SelfType of financial relationship:Investment Interest (Specialty Not Specified)Ineligible company:AbbvieDate added:Date updated:01/27/2022
-
Attribution:SelfType of financial relationship:Investment Interest (Specialty Not Specified)Ineligible company:Johnson and JohnsonDate added:Date updated:01/27/2022